Larry Merlo: The Alchemist

摘要

In march 2011, when larry Merlo became CEO of CVS Caremark Corp., he inherited some aches and pains. Fouryears earlier U.S. drugstore operator CVS had made a bold bet with its $26.5 billion acquisition of CaremarkRx, a pharmacy benefit manager (PBM) that serves as an intermediary between Pharmaceuticals companies and groups that pay for drugs, like insurance companies and corporations. Bythetime Merlo tookoverthe top job from longtime CEO Thomas Ryan, the deal was looking like abust, and some analysts were calling for CVS to spin off its Caremark business.